US Stock MarketDetailed Quotes

HTGMQ HTG Molecular Diagnostics

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Aug 26 16:00 ET
442.85Market Cap0.00P/E (TTM)

HTG Molecular Diagnostics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Total revenue
-12.83%1.03M
-28.52%6.37M
-15.22%2.44M
-50.37%1.25M
-28.09%1.49M
-17.47%1.18M
4.19%8.91M
11.38%2.88M
41.83%2.52M
5.65%2.07M
Operating revenue
-12.83%1.03M
-28.52%6.37M
-15.22%2.44M
-50.37%1.25M
-28.09%1.49M
-17.47%1.18M
4.19%8.91M
11.38%2.88M
41.83%2.52M
5.65%2.07M
Cost of revenue
34.45%1.15M
11.65%4.57M
49.95%2.03M
-31.81%670.86K
4.47%1.01M
8.90%855.05K
2.59%4.09M
27.77%1.35M
4.56%983.76K
-0.37%971.04K
Gross profit
-135.55%-117.1K
-62.72%1.79M
-73.22%407.55K
-62.25%580.02K
-56.75%477.11K
-49.32%329.41K
5.58%4.81M
-0.03%1.52M
83.76%1.54M
11.58%1.1M
Operating expense
-25.64%4.9M
-0.05%22.62M
-23.15%4.96M
-14.55%4.93M
18.68%6.15M
25.84%6.58M
-6.24%22.64M
16.34%6.45M
-4.00%5.77M
-13.41%5.19M
Selling and administrative expenses
-29.60%3.28M
-4.26%15.84M
-23.73%3.47M
-19.64%3.4M
10.33%4.31M
20.82%4.66M
-8.39%16.55M
3.90%4.55M
-10.94%4.23M
-8.26%3.9M
Research and development costs
-16.03%1.61M
11.38%6.78M
-21.75%1.49M
-0.51%1.53M
44.15%1.85M
39.97%1.92M
0.15%6.09M
63.09%1.9M
22.26%1.53M
-26.05%1.28M
Operating profit
19.85%-5.01M
-16.86%-20.83M
7.69%-4.55M
-2.78%-4.35M
-39.07%-5.68M
-36.50%-6.25M
9.00%-17.82M
-22.54%-4.93M
18.20%-4.23M
18.35%-4.08M
Net non-operating interest income expense
83.56%-39.96K
26.32%-762.38K
46.90%-137.97K
32.27%-174.89K
18.24%-206.43K
7.97%-243.1K
-34.36%-1.03M
2.01%-259.84K
-8.18%-258.21K
-38.14%-252.47K
Non-operating interest income
1,484.23%98.44K
215.74%94.36K
307.98%30.46K
205.17%25.6K
310.36%32.09K
0.03%6.21K
-88.27%29.88K
-26.83%7.47K
-75.79%8.39K
-88.50%7.82K
Non-operating interest expense
-44.49%138.4K
-19.52%856.73K
-36.99%168.42K
-24.80%200.48K
-8.37%238.52K
-7.78%249.31K
3.88%1.06M
-2.93%267.31K
-2.46%266.59K
3.80%260.29K
Other net income (expense)
-99.52%8.33K
3
8.33K
447.07%1.74M
0
432.28%1.74M
Special income (charges)
----
--0
--0
--0
--0
----
432.28%1.74M
--0
--0
432.28%1.74M
-Less:Other special charges
----
----
----
----
----
----
-432.28%-1.74M
--0
----
-432.28%-1.74M
Other non- operating income (expenses)
----
--8.33K
--3
--8.33K
----
----
----
----
----
----
Income before tax
22.23%-5.05M
-26.05%-21.58M
9.65%-4.69M
-0.58%-4.51M
-126.40%-5.88M
-34.08%-6.5M
17.90%-17.12M
-21.02%-5.19M
17.03%-4.49M
54.45%-2.6M
Income tax
474.61%2.22K
-51.78%10.84K
118.29%4K
-18.72%1.57K
-69.99%4.88K
-84.24%386
55.91%22.48K
-1.87%1.83K
22.33%1.93K
180.78%16.26K
Net income
22.20%-5.05M
-25.95%-21.59M
9.61%-4.69M
-0.57%-4.52M
-125.17%-5.89M
-34.02%-6.5M
17.85%-17.15M
-21.01%-5.19M
17.02%-4.49M
54.21%-2.61M
Net income continuous Operations
22.20%-5.05M
-25.95%-21.59M
9.61%-4.69M
-0.57%-4.52M
-125.17%-5.89M
-34.02%-6.5M
17.85%-17.15M
-21.01%-5.19M
17.02%-4.49M
54.21%-2.61M
Minority interest income
Net income attributable to the parent company
22.20%-5.05M
-25.95%-21.59M
9.61%-4.69M
-0.57%-4.52M
-125.17%-5.89M
-34.02%-6.5M
17.85%-17.15M
-21.01%-5.19M
17.02%-4.49M
54.21%-2.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.20%-5.05M
-25.95%-21.59M
9.61%-4.69M
-0.57%-4.52M
-125.17%-5.89M
-34.02%-6.5M
17.85%-17.15M
-21.01%-5.19M
17.02%-4.49M
54.21%-2.61M
Basic earnings per share
76.57%-2.28
18.14%-24.28
50.36%-4.12
31.67%-4.92
-38.46%-6.48
-1.35%-9.73
45.20%-29.66
16.67%-8.3
46.43%-7.2
70.00%-4.68
Diluted earnings per share
76.57%-2.28
18.14%-24.28
50.36%-4.12
31.67%-4.92
-38.46%-6.48
-1.35%-9.73
45.20%-29.66
16.67%-8.3
46.43%-7.2
70.00%-4.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Total revenue -12.83%1.03M-28.52%6.37M-15.22%2.44M-50.37%1.25M-28.09%1.49M-17.47%1.18M4.19%8.91M11.38%2.88M41.83%2.52M5.65%2.07M
Operating revenue -12.83%1.03M-28.52%6.37M-15.22%2.44M-50.37%1.25M-28.09%1.49M-17.47%1.18M4.19%8.91M11.38%2.88M41.83%2.52M5.65%2.07M
Cost of revenue 34.45%1.15M11.65%4.57M49.95%2.03M-31.81%670.86K4.47%1.01M8.90%855.05K2.59%4.09M27.77%1.35M4.56%983.76K-0.37%971.04K
Gross profit -135.55%-117.1K-62.72%1.79M-73.22%407.55K-62.25%580.02K-56.75%477.11K-49.32%329.41K5.58%4.81M-0.03%1.52M83.76%1.54M11.58%1.1M
Operating expense -25.64%4.9M-0.05%22.62M-23.15%4.96M-14.55%4.93M18.68%6.15M25.84%6.58M-6.24%22.64M16.34%6.45M-4.00%5.77M-13.41%5.19M
Selling and administrative expenses -29.60%3.28M-4.26%15.84M-23.73%3.47M-19.64%3.4M10.33%4.31M20.82%4.66M-8.39%16.55M3.90%4.55M-10.94%4.23M-8.26%3.9M
Research and development costs -16.03%1.61M11.38%6.78M-21.75%1.49M-0.51%1.53M44.15%1.85M39.97%1.92M0.15%6.09M63.09%1.9M22.26%1.53M-26.05%1.28M
Operating profit 19.85%-5.01M-16.86%-20.83M7.69%-4.55M-2.78%-4.35M-39.07%-5.68M-36.50%-6.25M9.00%-17.82M-22.54%-4.93M18.20%-4.23M18.35%-4.08M
Net non-operating interest income expense 83.56%-39.96K26.32%-762.38K46.90%-137.97K32.27%-174.89K18.24%-206.43K7.97%-243.1K-34.36%-1.03M2.01%-259.84K-8.18%-258.21K-38.14%-252.47K
Non-operating interest income 1,484.23%98.44K215.74%94.36K307.98%30.46K205.17%25.6K310.36%32.09K0.03%6.21K-88.27%29.88K-26.83%7.47K-75.79%8.39K-88.50%7.82K
Non-operating interest expense -44.49%138.4K-19.52%856.73K-36.99%168.42K-24.80%200.48K-8.37%238.52K-7.78%249.31K3.88%1.06M-2.93%267.31K-2.46%266.59K3.80%260.29K
Other net income (expense) -99.52%8.33K38.33K447.07%1.74M0432.28%1.74M
Special income (charges) ------0--0--0--0----432.28%1.74M--0--0432.28%1.74M
-Less:Other special charges -------------------------432.28%-1.74M--0-----432.28%-1.74M
Other non- operating income (expenses) ------8.33K--3--8.33K------------------------
Income before tax 22.23%-5.05M-26.05%-21.58M9.65%-4.69M-0.58%-4.51M-126.40%-5.88M-34.08%-6.5M17.90%-17.12M-21.02%-5.19M17.03%-4.49M54.45%-2.6M
Income tax 474.61%2.22K-51.78%10.84K118.29%4K-18.72%1.57K-69.99%4.88K-84.24%38655.91%22.48K-1.87%1.83K22.33%1.93K180.78%16.26K
Net income 22.20%-5.05M-25.95%-21.59M9.61%-4.69M-0.57%-4.52M-125.17%-5.89M-34.02%-6.5M17.85%-17.15M-21.01%-5.19M17.02%-4.49M54.21%-2.61M
Net income continuous Operations 22.20%-5.05M-25.95%-21.59M9.61%-4.69M-0.57%-4.52M-125.17%-5.89M-34.02%-6.5M17.85%-17.15M-21.01%-5.19M17.02%-4.49M54.21%-2.61M
Minority interest income
Net income attributable to the parent company 22.20%-5.05M-25.95%-21.59M9.61%-4.69M-0.57%-4.52M-125.17%-5.89M-34.02%-6.5M17.85%-17.15M-21.01%-5.19M17.02%-4.49M54.21%-2.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.20%-5.05M-25.95%-21.59M9.61%-4.69M-0.57%-4.52M-125.17%-5.89M-34.02%-6.5M17.85%-17.15M-21.01%-5.19M17.02%-4.49M54.21%-2.61M
Basic earnings per share 76.57%-2.2818.14%-24.2850.36%-4.1231.67%-4.92-38.46%-6.48-1.35%-9.7345.20%-29.6616.67%-8.346.43%-7.270.00%-4.68
Diluted earnings per share 76.57%-2.2818.14%-24.2850.36%-4.1231.67%-4.92-38.46%-6.48-1.35%-9.7345.20%-29.6616.67%-8.346.43%-7.270.00%-4.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.81%